Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Aoife_Brennan
|
| gptkbp:collaboratedWith |
gptkb:Ginkgo_Bioworks
gptkb:AbbVie gptkb:Roche |
| gptkbp:developedBy |
gptkb:enteric_hyperoxaluria
gptkb:phenylketonuria_(PKU) |
| gptkbp:focusesOn |
synthetic biology
microbiome therapeutics engineered biotherapeutics |
| gptkbp:founded |
2014
|
| gptkbp:founder |
gptkb:James_Collins
gptkb:Timothy_Lu |
| gptkbp:hasCompany |
true
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Synlogic, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:SYNB8802
gptkb:SYNB1618 gptkb:SYNB1934 |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:SYBX
|
| gptkbp:website |
https://www.synlogictx.com/
|
| gptkbp:bfsParent |
gptkb:SYBX
|
| gptkbp:bfsLayer |
7
|